Skip to main content
. 2024 Oct 14;60(10):1684. doi: 10.3390/medicina60101684

Figure 2.

Figure 2

Comparison of MIDAS scores before and after treatment (Erenumab and Topiramate). The diamond-shaped (♦) points represent outliers.